Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 0 results

Early research (Phase 1)Study completedNCT02647086
What this trial is testing

Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 14
Large-scale testing (Phase 3)Study completedNCT06361992
What this trial is testing

Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children

Who this might be right for
Atopic DermatitisAtopic Dermatitis and Related ConditionsAtopic Dermatitis Eczema+1 more
Catalysis SL 58
Early research (Phase 1)Looking for participantsNCT06808477
What this trial is testing

BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Bambusa Therapeutics 237
Large-scale testing (Phase 3)Study completedNCT05651711
What this trial is testing

A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

Who this might be right for
Atopic Dermatitis
Amgen 726